Search Site

ADNOC signs deal with PETRONAS

Under the agreement, ADNOC will supply 1m tons of LNG per year.

Aramco-Horse Powertrain deal completed

An agreement for the purchase of 10% equity stake was signed in June 2024.

Roche to buy Poseida Therapeutics

The $1.5 billion deal is due to close in early 2025.

BP announces $7bn gas project

The project aims to unlock 3 trillion cu ft of gas resources in Indonesia.

Lulu Retail Q3 profit $35m

For the nine-month period, net profit increased by 73.3%.

Credit Suisse fails NYSE listing criteria

The share price of Credit Suisse has hovered around $0.83. (AFP)
  • Credit Suisse is listed in New York under a "Depositary Shares" scheme that allows foreign firms to sell stock in the United States.
  • Its share price crumbled under the pressure of fears of contagion from the collapse of three US regional banks.

Zurich, Switzerland – Battered shares in crisis-hit Credit Suisse no longer meet criteria for listing on the New York Stock Exchange, the bank said Wednesday, adding that its upcoming sale to UBS would resolve the issue.

“The New York Stock Exchange notified Credit Suisse on May 1… that it is no longer in compliance with the NYSE’s continued listing minimum price criteria,” Credit Suisse said in a statement.

Credit Suisse is listed in New York under a “Depositary Shares” scheme that allows foreign firms to sell stock in the United States.

Under NYSE rules, shares must trade for at least $1.00 for 30 consecutive days to qualify for listing.

But the financial firm, whose share price crumbled under the pressure of fears of contagion from the collapse of three US regional banks, is slated to be taken over by historic rival UBS in a rescue organized by Bern.

Since the deal, the share price has hovered around 0.76 Swiss francs ($0.83) — in line with the three-billion-franc valuation for the acquisition and down around 94 percent compared with March 2021, before Credit Suisse was hit by a string of shocks and scandals.

“Credit Suisse expects that the deficiency will be cured upon completion of the acquisition by UBS,” which will mean its own shares are exchanged for UBS stock and delisted in New York, the statement said.